Stockreport

Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research Council

Lexaria Bioscience Corp.  (LEXX) 
PDF VIRAL-MC21-1 Demonstrates Stability of DehydraTECHâ„¢-Enabled Antiviral DrugsKELOWNA, BC / ACCESSWIRE / July 15, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW [Read more]